{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:17:20Z","timestamp":1795108640120,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801166"],"award-info":[{"award-number":["81801166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["14380478"],"award-info":[{"award-number":["14380478"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Neurosurg Jl"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the incidence, risk factors, and clinical prognosis of cerebral hyperperfusion syndrome (CHS) after superficial temporal artery-middle cerebral artery anastomosis combined with encephalo-duro-arterio-synangiosis (STA-MCA\/EDAS) in adult patients with moyamoya disease (MMD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The clinical data of 160 adult patients with MMD treated by STA-MCA\/EDAS from January 2016 to January 2017 were retrospectively analyzed. According to CHS diagnosis, MMD patients were divided into CHS and non-CHS group. Univariate and multivariate analysis of risk factors and Kaplan-Meier curve of stroke-free survival for CHS were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 12 patients (7.5%) developed postoperative CHS, of which 4 patients (2.5%) presented with cerebral hemorrhage. Univariate and multivariate analysis showed moyamoya vessel on the surgical hemisphere (<jats:italic>OR<\/jats:italic> = 3.04, 95% <jats:italic>CI<\/jats:italic> = 1.02\u20139.03, <jats:italic>P<\/jats:italic> = 0.046) and left operated hemisphere (<jats:italic>OR<\/jats:italic> = 5.16, 95% <jats:italic>CI<\/jats:italic> = 1.09\u201321.34, <jats:italic>P<\/jats:italic> = 0.041) were independent risk factors for CHS. The other variables, such as age, gender, presentation, hypertension, diabetes, smoking, mean mRS score on admission, modified Suzuki stage and pre-infarction stage on surgical hemisphere, and bypass patency, had no association with postoperative CHS (<jats:italic>P<\/jats:italic> &gt; 0.05). At final follow-up with average 38 months, there were 18 out of 133 patients (13.5%, 4.91% per person year) presented with newly developed complications. There was no significant difference between newly developed complications, mean mRS scores, and Kaplan-Meier curve of stroke-free survival in patients with and without CHS (<jats:italic>P<\/jats:italic> &gt; 0.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The concentration of moyamoya vessels and left operated hemisphere was independent risk factors for CHS, which could not affect the clinical prognosis if treated timely and properly. The current study offers a new perspective of moyamoya vessels and supporting data for choosing MMD candidates on cerebral revascularization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41016-023-00321-8","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:28:53Z","timestamp":1680517733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease"],"prefix":"10.1186","volume":"9","author":[{"given":"Zhiyong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056\u201366.","journal-title":"Lancet Neurol"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/BF00270916","volume":"4","author":"Y Maki","year":"1988","unstructured":"Maki Y, Enomoto T. Moyamoya disease. Childs Nerv Syst. 1988;4:204\u201312.","journal-title":"Childs Nerv Syst"},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0387-7604(85)80055-3","volume":"7","author":"Y Fukuyama","year":"1985","unstructured":"Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (\u201cmoyamoya\u201d disease) in children. Brain Dev. 1985;7:21\u201337.","journal-title":"Brain Dev"},{"issue":"Suppl 2","key":"321_CR4","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/S0303-8467(97)00058-9","volume":"99","author":"DH Han","year":"1997","unstructured":"Han DH, Nam DH, Oh CW. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg. 1997;99(Suppl 2):S151\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/0887-8994(85)90027-X","volume":"1","author":"T Kurokawa","year":"1985","unstructured":"Kurokawa T, Tomita S, Ueda K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol. 1985;1:274\u20137.","journal-title":"Pediatr Neurol"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337.","journal-title":"N Engl J Med"},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67:273\u201382.","journal-title":"Surg Neurol"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68:957\u201364 discussion 964-955.","journal-title":"Neurosurgery"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.surneu.2007.07.077","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009;71:223\u20137 discussion 227.","journal-title":"Surg Neurol"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1227\/01.NEU.0000369606.00861.91","volume":"66","author":"S Kuroda","year":"2010","unstructured":"Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66:1093\u2013101 discussion 1101.","journal-title":"Neurosurgery"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/01.STR.29.3.625","volume":"29","author":"Y Okada","year":"1998","unstructured":"Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C. Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke. 1998;29:625\u201330.","journal-title":"Stroke"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2019.10.JNS191207","volume":"134","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li S, Fujimura M, et al. Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease. J Neurosurg. 2019;134:17\u201324.","journal-title":"J Neurosurg."},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.surneu.2008.02.031","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71:442\u20137.","journal-title":"Surg Neurol"},{"issue":"1","key":"321_CR14","first-page":"1","volume":"3","author":"M Zhao","year":"2018","unstructured":"Zhao M, Deng X, Zhang D, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg. 2018;3(1):1\u201312.","journal-title":"J Neurosurg."},{"issue":"Suppl 2","key":"321_CR15","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","volume":"99","author":"M Fukui","year":"1997","unstructured":"Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(Suppl 2):S238\u201340.","journal-title":"Clin Neurol Neurosurg"},{"key":"321_CR16","first-page":"e10141","volume":"12","author":"A Gupta","year":"2020","unstructured":"Gupta A, Tyagi A, Romo M, Amoroso KC, Sonia F. Moyamoya disease: a review of current literature. Cureus. 2020;12:e10141.","journal-title":"Cureus"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.wneu.2016.07.087","volume":"95","author":"L Wang","year":"2016","unstructured":"Wang L, Qian C, Yu X, et al. Indirect bypass surgery may be more beneficial for symptomatic patients with moyamoya disease at early Suzuki stage. World Neurosurg. 2016;95:304\u20138.","journal-title":"World Neurosurg"},{"issue":"25","key":"321_CR18","first-page":"1","volume":"1","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Li J, Lu J, et al. Predictors of neoangiogenesis after indirect revascularization in moyamoya disease: a multicenter retrospective study. J Neurosurg. 2019;1(25):1\u201311.","journal-title":"J Neurosurg."},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/STROKEAHA.118.022628","volume":"49","author":"H Yin","year":"2018","unstructured":"Yin H, Liu X, Zhang D, et al. A novel staging system to evaluate cerebral hypoperfusion in patients with moyamoya disease. Stroke. 2018;49:2837\u201343.","journal-title":"Stroke"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1213\/00000539-199711000-00018","volume":"85","author":"T Sakamoto","year":"1997","unstructured":"Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg. 1997;85:1060\u20135.","journal-title":"Anesth Analg"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(05)70251-9","volume":"4","author":"WN van Mook","year":"2005","unstructured":"van Mook WN, Rennenberg RJ, Schurink GW, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005;4:877\u201388.","journal-title":"Lancet Neurol"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1227\/NEU.0000000000000139","volume":"73","author":"S Amin-Hanjani","year":"2013","unstructured":"Amin-Hanjani S, Singh A, Rifai H, et al. Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time. Neurosurgery. 2013;73:962\u20137 discussion 967-968.","journal-title":"Neurosurgery"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2009.01.FOCUS08293","volume":"26","author":"AA Baaj","year":"2009","unstructured":"Baaj AA, Agazzi S, Sayed ZA, Toledo M, Spetzler RF, van Loveren H. Surgical management of moyamoya disease: a review. Neurosurg Focus. 2009;26:E7.","journal-title":"Neurosurg Focus"},{"issue":"Suppl 2","key":"321_CR24","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1016\/S0303-8467(97)00075-9","volume":"99","author":"K Houkin","year":"1997","unstructured":"Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg. 1997;99(Suppl 2):S142\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3171\/2016.8.JNS152875","volume":"127","author":"DK Jang","year":"2017","unstructured":"Jang DK, Lee KS, Rha HK, et al. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. J Neurosurg. 2017;127:492\u2013502.","journal-title":"J Neurosurg"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis (Basel, Switzerland). 2012;33:436\u201345.","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1159\/000132205","volume":"25","author":"JE Kim","year":"2008","unstructured":"Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK. Transient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis. 2008;25:580\u20136.","journal-title":"Cerebrovasc Dis"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.surneu.2007.01.047","volume":"69","author":"S Ohue","year":"2008","unstructured":"Ohue S, Kumon Y, Kohno K, Watanabe H, Iwata S, Ohnishi T. Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol. 2008;69:281\u20136 discussion 286-287.","journal-title":"Surg Neurol"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/02688697.2012.757294","volume":"27","author":"WG Zhao","year":"2013","unstructured":"Zhao WG, Luo Q, Jia JB, Yu JL. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease. Br J Neurosurg. 2013;27:321\u20135.","journal-title":"Br J Neurosurg"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.4.PEDS09478","volume":"6","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr. 2010;6:73\u201381.","journal-title":"J Neurosurg Pediatr"},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/1743132814Y.0000000432","volume":"37","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Niizuma K, Endo H, et al. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease. Neurol Res. 2015;37:131\u20138.","journal-title":"Neurol Res"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1227\/00006123-198408000-00006","volume":"15","author":"RC Heros","year":"1984","unstructured":"Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES. Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery. 1984;15:178\u201385.","journal-title":"Neurosurgery"},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3171\/2021.2.JNS204333","volume":"136","author":"NR Khan","year":"2022","unstructured":"Khan NR, Lu VM, Elarjani T, et al. One-donor, two-recipient extracranial-intracranial bypass series for moyamoya and cerebral occlusive disease: rationale, clinical and angiographic outcomes, and intraoperative blood flow analysis. J Neurosurg. 2022;136:627\u201336.","journal-title":"J Neurosurg."},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3171\/2009.4.JNS08585","volume":"111","author":"A Nakagawa","year":"2009","unstructured":"Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T. Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg. 2009;111:1158\u201364.","journal-title":"J Neurosurg"},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1016\/j.wneu.2019.05.116","volume":"129","author":"C Tan","year":"2019","unstructured":"Tan C, Niu H, Duan R, et al. Abnormal embryonic development of cerebral arteries as a potential cause of moyamoya disease. World Neurosurg. 2019;129:e224\u201332.","journal-title":"World Neurosurg"},{"key":"321_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02985101","volume":"18","author":"R Piao","year":"2004","unstructured":"Piao R, Oku N, Kitagawa K, et al. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med. 2004;18:115\u201321.","journal-title":"Ann Nucl Med."},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/svn-2019-000317","volume":"6","author":"Z Shi","year":"2021","unstructured":"Shi Z, Ma G, Zhang D. Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings. Stroke Vasc Neurol. 2021;6:41\u20137.","journal-title":"Stroke Vasc Neurol"},{"key":"321_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3171\/2016.9.PEDS16161","volume":"19","author":"A Storey","year":"2017","unstructured":"Storey A, Michael Scott R, Robertson R, Smith E. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. J Neurosurg Pediatr. 2017;19:289\u201395.","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"321_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/NEU.0000000000000238","volume":"74","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, et al. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014;74(2):163\u201370 discussion 170.","journal-title":"Neurosurgery"},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","volume":"25","author":"S Yamada","year":"2016","unstructured":"Yamada S, Oki K, Itoh Y, et al. Effects of surgery and antiplatelet therapy in ten-year follow-up from the Registry Study of Research Committee on Moyamoya Disease in Japan. J Stroke Cerebrovasc Dis. 2016;25:340\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"321_CR41","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3171\/2015.6.JNS151105","volume":"124","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Kwon OK, et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg. 2016;124:1788\u201393.","journal-title":"J Neurosurg"},{"key":"321_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jns.2015.11.018","volume":"359","author":"HJ Noh","year":"2015","unstructured":"Noh HJ, Kim SJ, Kim JS, et al. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease. J Neurol Sci. 2015;359:381\u20138.","journal-title":"J Neurol Sci"}],"container-title":["Chinese Neurosurgical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-023-00321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41016-023-00321-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-023-00321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:38:28Z","timestamp":1680518308000},"score":1,"resource":{"primary":{"URL":"https:\/\/cnjournal.biomedcentral.com\/articles\/10.1186\/s41016-023-00321-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1186\/s41016-023-00321-8","relation":{},"ISSN":["2057-4967"],"issn-type":[{"value":"2057-4967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Nanjing Drum Tower Hospital, and written informed consent was obtained from all patients on admission. The ethics number was ChiCTR2000032529.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}